Ms Devora Allon > Kirkland & Ellis LLP > New York, United States > Lawyer Profile
Kirkland & Ellis LLP Offices
![Kirkland & Ellis LLP company logo](https://www.legal500.com/wp-content/uploads/sites/13/2022/05/53108.jpg?v=1653404167)
601 LEXINGTON AVENUE
NEW YORK, NY 10022
NEW YORK
United States
- Firm Profile
- Go to...
Ms Devora Allon
![Devora Allon photo](https://www.legal500.com/wp-content/uploads/sites/13/2023/07/53108_1244307.jpg)
Position
Devora Allon is a litigation partner in Kirkland’s New York office. She has a broad practice with a particular focus on antitrust, M&A, product liability and other commercial disputes. Devora has significant trial experience, securing five trial wins since 2015; three in 2018 alone. Her clients have included Bain Capital, Vista Equity Partners, Teva, Sun Pharma, Starwood Capital Group and the State of Georgia.
Education
Columbia Law School J.D.2008; Yeshiva University, Stern College for Women B.A., Literature magna cum laude 2005 Dean’s List
Lawyer Rankings
United States > Antitrust > Civil litigation/class actions: defense
With a notable and strong track record with contentious merger clearances, both domestic and international, the antitrust and competition team at Kirkland & Ellis LLP regularly represents leading healthcare, pharma, and life sciences sector clients on the full range of contentious antitrust matters, including reverse payment cases, IP-related antitrust litigation, and monopolization claims. Recent work highlights for the team include securing a complete defense verdict for Gilead Sciences in a class action involving claims of reverse payments. Key names in the team’s Chicago office include James Mutchnik and Daniel Laytin; Mutchnik focuses on cartel-related litigation, including price-fixing and monopolization claims, while Laytin has long-standing expertise advising on the full spectrum of contentious antitrust issues. Also in Chicago is Christa Cottrell, who handles large class actions in the pharma and healthcare space. Olivia Adendorff splits her time between Dallas and Washington DC and is another name to note for class actions, while Devora Allon handles pay-for-delay cases from New York.
United States > Healthcare > Life sciences
Kirkland & Ellis LLP‘s life sciences work brings together a number of the firm’s departments, together handling antitrust proceedings in the sector, while also representing pharmaceutical companies in product liability and personal injury litigation. Such disputes are the domain of Jay Lefkowitz, who also handles False Claims Act and shareholder litigation before Circuit Courts of Appeal and the Supreme Court. Further antitrust litigation experience comes in the form of Devora Allon, who also handles a broad range of commercial litigation. Patent litigation covering pharmaceuticals, medical devices and biotechnology is handled by Jeanna Wacker, and she is also consulted on the IP aspects of corporate and asset transactions. All lawyers mentioned are based in New York.
Lawyer Rankings
- Civil litigation/class actions: defense United States > Antitrust
- Life sciences United States > Healthcare
Top Tier Firm Rankings
- Media, technology and telecoms > Advertising and marketing: litigation
- Finance > Capital markets: high-yield debt offerings
- International trade > CFIUS
- Antitrust > Civil litigation/class actions: defense
- Government > Government relations
- Intellectual property > Copyright
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Energy > Energy litigation: oil and gas
- Energy > Energy transactions: electric power
- Energy > Energy transactions: oil and gas
- Environment > Environment: transactional
- Dispute resolution > General commercial disputes
- Tax > International tax
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Intellectual property > Patents: litigation (full coverage)
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Investment fund formation and management > Private equity funds (including venture capital)
- Real estate > Real estate
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Securities litigation: defense
- Media, technology and telecoms > Technology transactions
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Intellectual property > Trademarks: litigation
- Tax > US taxes: non-contentious
Firm Rankings
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Antitrust > Cartel
- Energy > Energy regulation: electric power
- Antitrust > Merger control
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Media, technology and telecoms > Outsourcing
- Intellectual property > Patents: licensing
- Intellectual property > Patents: litigation (International Trade Commission)
- Dispute resolution > Product liability, mass tort and class action - defense: automotive/transport
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Real estate > Real estate investment trusts (REITs)
- Energy > Renewable/alternative power
- Government > State attorneys general
- Finance > Structured finance: securitization
- Tax > US taxes: contentious
- Dispute resolution > E-discovery
- Environment > Environment: litigation
- Dispute resolution > Financial services litigation
- Insurance > Insurance: non-contentious
- Media, technology and telecoms > Media and entertainment: litigation
- Media, technology and telecoms > Media and entertainment: transactional
- Finance > Project finance
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- International trade > Customs, export controls and economic sanctions
- Energy > Energy regulation: oil and gas
- Healthcare > Life sciences
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending
- M&A/corporate and commercial > Shareholder activism